June 28, 2013
IMBA Symposium "Thinking the Unthinkable - The Future of Biology"
IMBA will celebrate “10 Years of Research” on June 27-28, 2013
May 27, 2013
Eighth Microsymposium on small RNAs
As in the last 7 years, the Microsymposium on Small RNAs will take place again at IMBA in May 2013, from Monday 27th in the morning to Wednesday 29th...
April 25, 2013
IMBA researchers find potential therapeutic approach against kidney failure
Focal segmental glomerulosclerosis (FSGS) is a severe disease that results in complete kidney failure (end-stage renal disease). If untreated or if a patient does not respond to therapy, dialysis becomes essential 2-3 times per week. While several genetic mutations are described and drug abuse or hypertension can cause FSGS, for the majority of FSGS cases the underlying cause remains elusive.
March 10, 2013
Mutated gene causes nerve cell death
Researchers identify new mechanism in the onset of incurable nerve disease Stephen Hawking, a British astrophysicist, is likely to be the world's most famous person living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. ALS is a progressive disease affecting motor neurons, nerve cells that control muscle function, and nearly always leads to death. Researchers at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) in Vienna have now identified a completely new mechanism in the onset of motor neuron diseases. Their findings could be the basis for future treatments for these presently incurable diseases.
December 11, 2012
Jürgen Knoblich receives Erwin Schrödinger Prize 2012
The molecular biologist is awarded for his outstanding work in the field of stem cell research